Inify Laboratories enter into agreement with Swedish region
Inify Laboratories, a unique laboratory service that performs cancer diagnostics within pathology, has entered into an agreement with the region…
0,410€
1,23%
Echtzeit-Aktienkurs INIFY Laboratories AB
Bid:
Ask:
Nachrichten zur INIFY Laboratories AB Aktie
Inify Laboratories – Registration of prospectus and upcoming launch of Subsequent Offering
STOCKHOLM – 7 January 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the…
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed subsequent repair issue
STOCKHOLM – 9 December 2024 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the…
Inify Laboratories AB (publ) - Bulletin from the extraordinary general meeting
Today, December 6, 2024, INIFY Laboratories AB, org. no. 559345-4431 (the "Company") held an extraordinary general meeting. A total of…
Inify Laboratories - notice of Extraordinary General Meeting on December 6, 2024
Stockholm – November 15, 2024 - Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics,…
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million
STOCKHOLM – November 15, 2024 – reference is made to the stock exchange announcement made by Inify Laboratories AB (“Inify”…
Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer
STOCKHOLM – November 05, 2024 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, is proud…
Inify Laboratories: Establishment in the United Kingdom and expansion into gastrointestinal diagnostics
STOCKHOLM - October 23, 2024 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has after…
Inify Laboratories gets honorable mention by the Royal Swedish Academy of Engineering Sciences (IVA) at the Smart Industry business competition 2024
STOCKHOLM - October 10, 2024 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology received an…
Panel talk about Inify’s second quarter 2024
"We are saving weeks in waiting time for patients to get the diagnosis".
This and more value that Inify Laboratories can…
INIFY Laboratories: 62% revenue growth and strong international interest
STOCKHOLM - August 21, 2024 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to…
Inify Laboratories AB (publ) – summary of Annual General Meeting
Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting at the companys premises on May 14,…
Inify Laboratories - Annual Report 2023
Stockholm – April 11, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its…
Inify Laboratories – notice of Annual General Meeting on May 14, 2024
Stockholm – April 11, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics,…
Panel talk about Inify’s fourth quarter 2023
Listen to CEO Fredrik Palm and Sales & Marketing Manager Maria Holmberg in this panel talk, moderated by Ole Eikeland,…
Inify Laboratories receives accreditation as a medical laboratory
STOCKHOLM - November 6, 2023 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics in pathology, has received…
Inify Laboratories - Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosis
STOCKHOLM - August 23, 2023 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, successfully launched…
Inify Laboratories - mandatory notification of trade
Stockholm, Sweden, July 5, 2023; Inify Laboratories AB (publ.) has been notified that the following transaction has been completed by…
Finansavisen highlights Inify Laboratories
Norwegian financial newspaper Finansavisen highlights Inify Laboratories in a report from the laboratory in Solna. CEO Fredrik Palm and Chief…
Inify Laboratories AB (publ) – summary of Annual General Meeting
Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders Annual General Meeting at the companys premises on May 16,…
ContextVision distributes cash dividend of SEK 0.30 per share
STOCKHOLM – May 3[rd], 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today…
Inify Laboratories - Strong market interest and launch on track
STOCKHOLM – April 26[th], 2023 – Inify Laboratories, a fully integrated digital ultramodern laboratory service that provides cancer diagnostics within…
Inify Laboratories - Annual Report 2022
Stockholm – April 12, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, presents…
Inify Laboratories - notice of Annual General Meeting on May 16, 2023
Stockholm – April 12, 2023 – Inify Laboratories AB (publ), a company providing fully digitalized laboratory services within prostate cancer…
Annual report 2022 – record sales with full focus on growing the core business
STOCKHOLM – March 30th, 2023- ContextVision, a medical technology software company specializing in image processing and image analysis, today presents…
Inify Laboratories - Ultramodern AI-based digital pathology laboratory completed in record time
STOCKHOLM – February 22, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, has…